ALLERGAN INC
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | |
|---|---|---|---|---|---|---|
| Revenue | $7.24B | $6.30B | $5.65B | $5.22B | $4.92B | $4.50B |
| Operating income | $2.01B | $1.81B | $1.61B | $1.37B | $258.6M | $928.0M |
| Net income | $1.52B | $985.1M | $1.10B | $934.5M | $600,000 | $621.3M |
| Total assets | $12.42B | $10.57B | $9.18B | $8.51B | $8.31B | $7.54B |
| Total liabilities | — | — | — | — | — | — |
| Equity | $7.75B | $6.46B | $5.84B | $5.31B | $4.76B | $4.82B |
| EPS (diluted) | $5.01 | $3.26 | $3.58 | $3.01 | $0.00 | $2.03 |
| Shares out. | 307.6M | 307.5M | 307.5M | 307.5M | 307.5M | 305.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2014- Operating margin
- 27.8%
- Net margin
- 21.1%
- Return on equity
- 19.7%
- Return on assets
- 12.3%
- Return on capital (ROCE)
- 18.5%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $25.21
- Revenue growth (YoY)
- 14.9%
- Net income growth (YoY)
- 54.7%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2014- Accruals / assets
- −3.3%clean
- Piotroski F-Score
- 5/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 5 good- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
FDA-approved drugs
openFDA · most recent- GELNIQUE 3%Dec 7, 2011
- TRETINOINMar 22, 2010
- TRIVARISJun 16, 2008
- BYSTOLICDec 17, 2007
- SANCTURA XRAug 3, 2007
- NAMENDAApr 18, 2005
- SANCTURAMay 28, 2004
- ELESTATOct 16, 2003
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsMar 18, 2015
- Shareholder vote · Other material eventMar 11, 2015
- Results of operations · Other material eventFeb 4, 2015
- Other material eventJan 12, 2015
- Other material eventDec 1, 2014
- Entered a material agreement · Other material eventNov 18, 2014
- Amended charter or bylaws · Other material eventNov 12, 2014
- Other material eventOct 27, 2014
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 10, 2016
- 15-15DFORM 15Apr 17, 2015
- 15-15DFORM 15Apr 17, 2015
- 15-15DFORM 15Apr 17, 2015
- 15-12BFORM 15Mar 27, 2015
- SC 13D/AAMENDMENT NO. 15 TO SCHEDULE 13DMar 23, 2015
- 4PRIMARY DOCUMENTMar 19, 2015
- 4PRIMARY DOCUMENTMar 19, 2015
- 4PRIMARY DOCUMENTMar 19, 2015
- 4PRIMARY DOCUMENTMar 19, 2015
- 4PRIMARY DOCUMENTMar 19, 2015
- 4PRIMARY DOCUMENTMar 19, 2015
- 4PRIMARY DOCUMENTMar 19, 2015
- 4PRIMARY DOCUMENTMar 19, 2015
- 4PRIMARY DOCUMENTMar 19, 2015
Event-driven situations (4)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.